Vishat Diagnostics receives ICMR nod for COVID-19 rapid testing antigen kit

Vishat Diagnostics receives ICMR nod for COVID-19 rapid testing antigen kit

Vishat Diagnostics recently received approval from the Indian Council of Medical Research (ICMR) for supplying COVID-19 rapid testing antigen kit manufactured by Coris BioConcept.

Vishat plans to launch the testing kit named as, ‘COVID-19 Ag Respi-Strip’, at a price of ₹425, the company said in a statement.

The kit works with nasopharyngeal swabs and can show results in a span of 15 minutes. The kit tests for antibodies in the user to determine whether they have encountered COVID-19 infection.

The CE certified kit has been developed by Belgium-based firm Coris BioConcept, and is used in several European countries and in North America, the company said.